FdaApplication
NDA 021224
Identifiers
- fda_app_no: NDA021224
Properties
| Property | Value |
|---|---|
| applicant_name | JANSSEN PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2001-06-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RAZADYNE | GALANTAMINE HYDROBROMIDE | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;ORAL |
1 product